Natarajan Sethuraman, President, Research & Develop: Entrada Therapeutics TRDA Planned sale · Filed 05/04

Trade details

Type: Planned sale notice
Stock: Entrada Therapeutics TRDA
Person: Natarajan SethuramanPresident, Research & Develop
Planned sale date: 26/05/04
Filed: 26/05/04

More to sell after $134.5K in 3 months

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 04/04~06/03

Natarajan Sethuraman's recent trades

Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$398.7K
25,907 sh
$398.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$235.8K
11,703 sh
$235.8K
Filed 24/12/03
Traded 24/12/03
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$82.8K
4,088 sh
$82.8K
Filed 24/12/03
Traded 24/12/02
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$2,000
100 sh
$2,000
Filed 24/12/03
Traded 24/11/29
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$54.1K
2,700 sh
$54.1K
Filed 24/11/13
Traded 24/11/13

Natarajan Sethuraman, President — plans to sell 25,907 sh of Entrada Therapeutics TRDA · $375.7K · around 05/04 · 10b5-1 plan | Whalegun